Had another NR today. Hopefully will be an up day tomorrow. Looks like more good results.
January 4, 2006 - 4:02 PM EST
CytoGenix Announces Results of synDNA(TM) Smallpox Vaccine Study
CytoGenix, Inc. (OTCBB:CYGX) announced positive results of an animal study designed and conducted by the laboratory of Dr. David Weiner at the University of Pennsylvania Medical School Philadelphia. These tests demonstrated that a CytoGenix technique for generating synthetic DNA vaccines called synDNA(TM) as an smallpox vaccine, was highly potent in generating an immune response.
DNA vaccines are comprised of genes that confer immunologic protection by producing antigens without the need to expose the body to pathogenic organisms. For this study, CytoGenix scientists prepared a synDNA(TM) vaccine containing a gene sequence provided by Dr. Weiner that produces a protein that is an essential component of the smallpox virus.
Scientists in Dr. Weiner's laboratory tested and compared levels of antibodies and killer T cells produced in mice by the synDNA(TM) smallpox vaccine to a traditional plasmid DNA vaccine. The synDNA(TM) vaccine generated immunoglobulin and T cell levels in test animals several times greater than a comparable plasmid DNA vaccine produced by bacterial fermentation.
Dr. David B. Weiner, Associate Professor, University of Pennsylvania Medical School, Department of Pathology and Laboratory Medicine, a leading expert in DNA vaccines, commented, "We are impressed with the results from this study, the data, while preliminary are exciting."
Frank Vazquez, CytoGenix, Inc.'s Executive Vice President and COO, commented, "These results confirm the effectiveness of synDNA(TM) vaccines in producing substantial immunologic activity. The positive results we have achieved with our DNA vaccine tests are an excellent foundation for developing vaccines against biodefense related targets and for Avian Influenza H5N1."